| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |